Work

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

Year: 2008

Type: article

Source: Journal of Hypertension

DOI: 10.1097/hjh.0b013e3282f35c67

Authors: Roland E Schmieder, Sverre E Kjeldsen, Stevo Julius, Gordon T McInnes, Alberto Zanchetti, Tsushung A Hua

Institutions: Friedrich-Alexander-Universität Erlangen-Nürnberg, Oslo University Hospital, University of Oslo, University of Michigan, University of Glasgow, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, IRCCS Istituto Auxologico Italiano, Novartis (United States)

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Novartis, Novartis Pharma

OpenAlex ID: W1978481506

FWCI: 21.2

Cites: 31

Cited by: 232

Related to: 10